Nuo Therapeutics Inc (AURX)
0.80
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Nuo Therapeutics Price to Book Value: 34.06 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 34.06 |
| April 30, 2024 | 34.06 |
| April 29, 2024 | 34.06 |
| April 26, 2024 | 34.06 |
| April 25, 2024 | 34.06 |
| April 24, 2024 | 34.06 |
| April 23, 2024 | 34.06 |
| April 22, 2024 | 34.06 |
| April 19, 2024 | 34.06 |
| April 18, 2024 | 34.06 |
| April 17, 2024 | 31.93 |
| April 16, 2024 | 40.45 |
| April 15, 2024 | 40.45 |
| April 12, 2024 | 40.45 |
| April 11, 2024 | 40.45 |
| April 10, 2024 | 40.45 |
| April 09, 2024 | 40.45 |
| April 08, 2024 | 40.45 |
| April 05, 2024 | 40.45 |
| April 04, 2024 | 40.45 |
| April 03, 2024 | 41.72 |
| April 02, 2024 | 41.72 |
| April 01, 2024 | 41.72 |
| March 28, 2024 | 38.32 |
| March 27, 2024 | 38.32 |
| Date | Value |
|---|---|
| March 26, 2024 | 38.32 |
| March 25, 2024 | 38.32 |
| March 22, 2024 | 38.32 |
| March 21, 2024 | 38.32 |
| March 20, 2024 | 38.32 |
| March 19, 2024 | 38.32 |
| March 18, 2024 | 38.32 |
| March 15, 2024 | 38.31 |
| March 14, 2024 | 38.32 |
| March 13, 2024 | 38.32 |
| March 12, 2024 | 38.32 |
| March 11, 2024 | 38.32 |
| March 08, 2024 | 38.32 |
| March 07, 2024 | 37.34 |
| March 06, 2024 | 37.34 |
| March 05, 2024 | 27.67 |
| March 04, 2024 | 27.67 |
| March 01, 2024 | 27.67 |
| February 29, 2024 | 27.67 |
| February 28, 2024 | 27.67 |
| February 27, 2024 | 27.67 |
| February 26, 2024 | 27.66 |
| February 23, 2024 | 24.69 |
| February 22, 2024 | 24.69 |
| February 21, 2024 | 24.69 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0047
Minimum
Dec 31 2021
133.16
Maximum
Jun 30 2023
38.88
Average
33.92
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.065 |
| Perspective Therapeutics Inc | 14.17 |
| Protalix BioTherapeutics Inc | 2.557 |
| Electromed Inc | 3.788 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 55.32 |
| PEG Ratio | -0.70 |
| Price | 0.80 |
| Earnings Yield | -10.00% |
| Market Cap | 35.39M |
| PEGY Ratio | -0.70 |